This regulatory mechanism partly explained why PDTC treatment inhibited NFκB activation, promoted HCC cells apoptosis and suppressed tumor growth [53], while LPS treatment induced NFκB activation and promoted tumor cell proliferation and metastatic growth [54], [55], [56], [57]. Here, NFKB1 is linked to hepatocellular carcinoma.